Merck
MRK
2,993 hedge funds and large institutions have $163B invested in Merck in 2022 Q3 according to their latest regulatory filings, with 122 funds opening new positions, 1,378 increasing their positions, 1,112 reducing their positions, and 104 closing their positions.
37% more call options, than puts
Call options by funds: $2.4B | Put options by funds: $1.76B
24% more repeat investments, than reductions
Existing positions increased: 1,378 | Existing positions reduced: 1,112
17% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 104
0.18% more ownership
Funds ownership: 74.29% → 74.48% (+0.18%)
1% less funds holding
Funds holding: 3,016 → 2,993 (-23)
5% less capital invested
Capital invested by funds: $172B → $163B (-$8.79B)
6% less funds holding in top 10
Funds holding in top 10: 238 → 224 (-14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aristotle Capital Management
Los Angeles,
California
|
+$793M |
| 2 |
Amundi
Paris,
France
|
+$305M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$293M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$275M |
| 5 |
N
Natixis
Paris,
France
|
+$251M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$459M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$373M |
| 3 |
Renaissance Technologies
New York
|
-$196M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$160M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$158M |
MRK Hedge Fund Activity: Q3 2022 in Review
2,993 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2022, worth a combined $163B — down 5.1% from $172B a quarter earlier.
Buyers outnumbered sellers: 122 funds opened new MRK positions and 104 closed out — a net gain of 18 holders — while 1,378 added to existing stakes and 1,112 trimmed.
The largest buyer was Aristotle Capital Management, opening a new position worth an estimated $793M. The largest seller was Marshall Wace, cutting an estimated $459M.
- 2,993 institutional investors held Merck (MRK) as of Q3 2022, down from 3,016 in Q2 2022.
- Funds reported $163B of Merck stock for Q3 2022, down 5.1% quarter-over-quarter.
- 122 funds opened new Merck positions in Q3 2022 and 104 closed out, a net change of +18 holders.
- The largest Merck buyer in Q3 2022 was Aristotle Capital Management, an estimated $793M added.
- The largest Merck seller in Q3 2022 was Marshall Wace, an estimated $459M sold.
Based on aggregated 13F filings for Q3 2022.